文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

挖掘新型诊断和预后长链非编码 RNA(lncRNA)对头颈鳞状细胞癌的作用:竞争性内源性 RNA(ceRNA)和基因共表达网络的综合生物信息学分析。

Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.

机构信息

Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.

Faculty of Medicine, Amsterdam UMC, Univ of Amsterdam, Amsterdam, Netherlands.

出版信息

Bioengineered. 2021 Dec;12(2):12821-12838. doi: 10.1080/21655979.2021.2003925.


DOI:10.1080/21655979.2021.2003925
PMID:34898376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8810019/
Abstract

Long non-coding RNAs (lncRNAs) have been demonstrated to fine-tune gene regulations that govern a broad spectrum of oncogenic processes. Nonetheless, our understanding of the roles of lncRNAs and their interactions with miRNAs and mRNAs in HNSCC is still highly rudimentary. Here, we present a comprehensive bioinformatics analysis in which competing endogenous RNA (ceRNA) network construction and weighted gene co-expression network analysis (WGCNA) were combined to explore novel diagnostic and prognostic lncRNAs for HNSCC. Differentially expressed mRNAs (DEGs), miRNAs (DEMs) and lncRNAs (DELs) were identified based on the RNA sequencing data and clinical data retrieved from TCGA database. LncRNA-regulated ceRNA networks were constructed based on the interactive RNA pairs predicted by miRDB, miRcode and TargetScan. WGCNA was conducted to identify lncRNAs that were significantly correlated with patient overall survival (OS) and HNSCC tumor. RT-qPCR was employed to validate the expression of lncRNAs in HNSCC cell lines and patient sera. A ceRNA network consisting of 90 DEGs, 7 DEMs and 67 DELs associated with clinical traits was established. WGCNA and Kaplan-Meier survival analysis revealed that 5 DELs (MIR4435-2 HG, CASC9, LINC01980, STARD4-AS1 and MIR99AHG) were significantly correlated with OS of HNSCC patients, whereas DEL PART1 was most significantly correlated with the HNSCC tumor. The predicted expression patterns of PART1, LINC01980 and MIR4435-2 HG were further validated in HNSCC cell lines and patient sera. Collectively, the present study provided novel insights into the lncRNA-regulated ceRNA networks in HNSCC and identified novel lncRNAs that harbor diagnostic and prognostic potentials for HNSCC. BP, biological process. CC, cellular component. ceRNA, competing endogenous RNA. DEG, differential expressions of mRNA. DEL, differentially expressed lncRNA. DEM, differentially expressed miRNA. ESCC, esophageal squamous cell carcinoma. FPKM, Fragments Per Kilobase Million. GO, Gene Ontology. GS, gene significance. HNSCC, head and neck squamous cell carcinoma. KEGG, Kyoto Encyclopedia of Genes and Genomes. LncRNA, long non-coding RNA. MCC, Maximal Clique Centrality. ME, module eigengenes. MF, molecular functions. MM, module membership. MRE, miRNA-binding site. MYO5A, Myosin-Va. PART1, prostate androgen-regulated transcript 1. RBM3, RNA‑binding motif protein 3. TCGA, The Cancer Genome Atlas. TOM, topological overlap measure. TSCC, tongue squamous cell carcinoma. WGCNA, weighted gene co-expression network analysis.

摘要

长链非编码 RNA(lncRNA)已被证明可以精细调节基因调控,从而控制广泛的致癌过程。尽管如此,我们对 lncRNA 的作用及其与 miRNA 和 mRNA 在 HNSCC 中的相互作用的理解仍然非常基础。在这里,我们进行了一项全面的生物信息学分析,结合竞争性内源 RNA(ceRNA)网络构建和加权基因共表达网络分析(WGCNA),探索用于 HNSCC 的新型诊断和预后 lncRNA。根据 TCGA 数据库中检索的 RNA 测序数据和临床数据,鉴定差异表达的 mRNA(DEGs)、miRNA(DEMs)和 lncRNA(DELs)。基于 miRDB、miRcode 和 TargetScan 预测的互作 RNA 对构建 lncRNA 调控的 ceRNA 网络。进行 WGCNA 以鉴定与患者总生存期(OS)和 HNSCC 肿瘤显著相关的 lncRNA。实时定量 qPCR 用于验证 HNSCC 细胞系和患者血清中 lncRNA 的表达。建立了一个包含 90 个与临床特征相关的 DEG、7 个 DEM 和 67 个 DEL 的 ceRNA 网络。WGCNA 和 Kaplan-Meier 生存分析显示,5 个 DEL(MIR4435-2HG、CASC9、LINC01980、STARD4-AS1 和 MIR99AHG)与 HNSCC 患者的 OS 显著相关,而 DEL PART1 与 HNSCC 肿瘤最显著相关。PART1、LINC01980 和 MIR4435-2HG 的预测表达模式在 HNSCC 细胞系和患者血清中进一步得到验证。总之,本研究提供了 HNSCC 中 lncRNA 调控 ceRNA 网络的新见解,并鉴定了具有 HNSCC 诊断和预后潜力的新型 lncRNA。BP,生物过程。CC,细胞成分。ceRNA,竞争性内源 RNA。DEG,mRNA 的差异表达。DEL,差异表达的 lncRNA。DEM,差异表达的 miRNA。ESCC,食管鳞状细胞癌。FPKM,片段每百万碱基数。GO,基因本体论。GS,基因意义。HNSCC,头颈部鳞状细胞癌。KEGG,京都基因与基因组百科全书。LncRNA,长链非编码 RNA。MCC,最大团中心度。ME,模块特征基因。MF,分子功能。MM,模块成员。MRE,miRNA 结合位点。MYO5A,肌球蛋白-Va。PART1,前列腺雄激素调节转录物 1。RBM3,RNA 结合基序蛋白 3。TCGA,癌症基因组图谱。TOM,拓扑重叠度量。TSCC,舌鳞状细胞癌。WGCNA,加权基因共表达网络分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/8b232ac4609f/KBIE_A_2003925_F0008_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/e1f46913aa1a/KBIE_A_2003925_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/3ae28f8a3a95/KBIE_A_2003925_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/32d58598528c/KBIE_A_2003925_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/0080dbc44b85/KBIE_A_2003925_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/1738ad0492fd/KBIE_A_2003925_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/44334f5df4fb/KBIE_A_2003925_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/3d8771c527fd/KBIE_A_2003925_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/8b232ac4609f/KBIE_A_2003925_F0008_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/e1f46913aa1a/KBIE_A_2003925_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/3ae28f8a3a95/KBIE_A_2003925_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/32d58598528c/KBIE_A_2003925_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/0080dbc44b85/KBIE_A_2003925_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/1738ad0492fd/KBIE_A_2003925_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/44334f5df4fb/KBIE_A_2003925_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/3d8771c527fd/KBIE_A_2003925_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402d/8810019/8b232ac4609f/KBIE_A_2003925_F0008_B.jpg

相似文献

[1]
Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.

Bioengineered. 2021-12

[2]
Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma.

Medicine (Baltimore). 2022-8-19

[3]
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.

BMC Cancer. 2019-8-7

[4]
Comprehensive analysis of competitive endogenous RNAs network associated with head and neck squamous cell carcinoma.

Sci Rep. 2018-7-12

[5]
How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis.

Cell Physiol Biochem. 2018

[6]
Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.

BMC Med Genomics. 2020-3-30

[7]
Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.

J Cell Biochem. 2019-10

[8]
Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.

Cancer Biomark. 2020

[9]
Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.

Cell Physiol Biochem. 2018

[10]
An 11-lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma.

J Cell Biochem. 2019-10

引用本文的文献

[1]
Targeting STARD4/EGFR axis inhibits growth and overcomes lenvatinib resistance in hepatocellular carcinoma.

Genes Dis. 2025-2-15

[2]
Disentangled similarity graph attention heterogeneous biological memory network for predicting disease-associated miRNAs.

BMC Genomics. 2024-12-2

[3]
Construction of a tumor mutational burden-derived LncRNA prognostic computational framework associated with therapy sensitivity in skin cutaneous melanoma.

J Transl Med. 2024-10-24

[4]
BANF1 is a novel prognostic biomarker linked to immune infiltration in head and neck squamous cell carcinoma.

Front Immunol. 2024

[5]
Bioinformatic analysis indicated that STARD4-AS1 might be a novel ferroptosis-related biomarker of oral squamous cell carcinoma.

Heliyon. 2024-6-17

[6]
Differential regulation of STARD1, STARD4 and STARD6 in the human ovary.

J Endocrinol. 2024-8-1

[7]
Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis.

PLoS One. 2023

[8]
Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis.

Cancers (Basel). 2023-9-4

[9]
Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.

Turk J Med Sci. 2023-6

[10]
Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma.

Arch Toxicol. 2023-6

本文引用的文献

[1]
Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.

Front Mol Biosci. 2021-4-22

[2]
Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.

Oncol Rep. 2021-6

[3]
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet Oncol. 2021-4

[4]
Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.

Methods Mol Biol. 2021

[5]
lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.

J Cell Mol Med. 2020-9

[6]
LncRNA PART1 promotes cell proliferation and progression in non-small-cell lung cancer cells via sponging miR-17-5p.

J Cell Biochem. 2021-4

[7]
LncRNA PART1 Exerts Tumor-Suppressive Functions in Tongue Squamous Cell Carcinoma via miR-503-5p.

Onco Targets Ther. 2020-10-7

[8]
Concepts of extracellular matrix remodelling in tumour progression and metastasis.

Nat Commun. 2020-10-9

[9]
LINC01980 stimulates the progression of hepatocellular carcinoma via downregulating caspase 9.

J BUON. 2020

[10]
LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis.

Cancer Cell Int. 2020-5-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索